Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of T900607-Sodium in Chemotherapy Naive Hepatocellular Carcinoma
NCT00043433Phase 2Unknown
- Sponsor
- Tularik Inc.
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of t900607-sodium in hepatocellular carcinoma (HCC), sponsored by Tularik Inc.. Status: unknown.
02
Drugs
t900607-sodium
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00043433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043433.